Discussion
Wunderlich Syndrome (WS) is a rare but potentially fatal condition. This condition is more common in men and appears at an average age of 46 years, with most cases occurring between ages 30 and 60 years old. It usually occurs as an acute entity, but it presents less often in a more subtle but progressive manner. Given the rarity of WS and its life-threatening nature, it is important for a physician to recognize this entity since it is usually confused with other diseases, such as renal stones.
The most common manifestation of WS is flank or abdominal pain seen in 67% of patients, followed by hematuria, either microscopic or gross (40%), a flank mass, and hypovolemic shock (27%), which may all occur in concert or in isolation. The characteristic Lenk triad of flank mass, a flank pain, and hypovolemic shock is appreciated in only an estimated 20% of patients with WS. Proposed theories for developing WS include increased renal vein pressure, changes in intralesional tumor pressure due to blocked vasculature, necrosis and the damage of inherent tumor vasculature.
Most cases of WS have neoplastic and vascular causes. Angiomyolipomas and renal cell carcinomas (RCCs) are the most common benign and malignant neoplasms seen to have increased probability to cause WS. These are followed by pseudoaneurysms and rupture of renal artery aneurysms, vascular malformations, and vasculitis syndromes, including polyarteritis nodosa, as the second most common etiology. Acquired and hereditary renal cystic diseases, pregnancy, kidney failure, and iatrogenic causes (e.g. systemic anticoagulation) predispose patients to WS. Renal infections, calculus disease, and coagulation disorders are rare causes of WS.
The diagnosis can be complex, as it can mimic some acute abdominal pathologies. Ultrasound is highly sensitive and valuable for its rapid identification, but its findings must be confirmed with a CT scan. Ultrasound is often useful as a follow-up examination to assess the evolution of the hematoma as it may not allow identification of the cause in most patients with WS. On the other hand, contrast-enhanced CT scan provides additional information beyond that found with ultrasound techniques. It allows dynamic assessment of blood flow in perfused tissues. In addition, MRI may be performed to detect causes of WS in patients with whom the initial or follow-up CT scan did not yield source of bleeding. If the CT scan and MRI are unclear regarding etiology, angiogram is the next recommended approach. Catheter angiography helps to detect the source of bleeding and to identify the vascular causes of WS. Super-selective renovascular catheterization and embolization have increasingly been used as the first-line treatment for prompt control of life-threatening WS and avoidance of radical surgery. If radiological investigations fail to identify the cause, surgical exploration and biopsy is recommended.
There are several management recommendations, which depend on the presence of active bleeding and the patient’s general hemodynamic status. In cases of hemodynamic instability, an urgent radical nephrectomy or hemostasis by interventional radiology should be performed. When active extravasation is detected on imaging, angiography and embolization are the preferred approach, with partial or radical nephrectomy reserved for neoplastic causes or refractory bleeding. However, if hemodynamically stable as described in the case, recent studies suggest an initial trial of conservative therapy with hydration, pain management, blood product replacement, and volume resuscitation with intravenous fluids; if there is concern for an infectious etiology, appropriate antibiotic therapy should be started which had also been given to the patient above. Selective arterial embolization is another method to control active bleeding, and many authors recommend it as the definitive therapy. Serial CT scans should be performed to monitor bleeding afterwards. Nevertheless, nephrectomy is still the first-line approach.